Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus

Abstract

Background and objective

Recent evidence has demonstrated that mitochondria possess their own nitric oxide synthase (mtNOS) and can produce endogenous reactive-nitrogen-species (RNS) including peroxynitrite (ONOO^–). This study was undertaken to investigate the role of mitochondrial DNA (mtDNA) damage by ONOO^– in systemic lupus erythematosus (SLE) autoimmunity.

Methods

MtDNA was isolated from fresh goat liver and modified by ONOO^–, generated by synergistic action of nitric oxide (NO) and superoxide (O ^– ₂ ) donors. Modifications occurring in mtDNA were characterized by physicochemical techniques. SLE patients (n = 50) with varying disease activity according to the SLE Disease Activity Index (SLEDAI) and healthy controls (n = 34) were evaluated for antibodies to native and ONOO^–-modified mtDNA by immunoassays. Gel retardation assays were performed to cross-examine the immunoassay results using affinity-purified SLE immunoglobulin G (IgG). Nitrosative stress in SLE patients was studied by measuring nitrotyrosine and inducible NO synthase (iNOS).

Results

The ONOO^– caused extensive damage to mtDNA as evident by ultraviolet (UV) hyperchromicity and loss of florescence intensity. Thermal melting studies, agarose gel electrophoresis and nuclease S1 digestibility clearly indicate structural perturbation in mtDNA by ONOO^–. Quenching studies with specific NO or O ^– ₂ quenchers confirmed that the damaging agent was ONOO^–. SLE autoantibodies exhibited enhanced binding with ONOO^–-mtDNA as compared to their native analog. Interestingly, not only was there an increased number of subjects positive for ONOO ^– -mtDNA, but also the levels of anti-ONOO ^– -mtDNA antibodies were statistically significantly higher among SLE patients whose SLEDAI scores were ≥ 20 as compared with SLE patients with lower SLEDAI scores (SLEDAI < 20). Normal healthy controls showed negligible binding with either antigen. Furthermore, SLE patients had higher levels of nitrotyrosine and iNOS compared with their respective healthy controls.

Conclusions

Our novel results provide an important insight into the immunological basis of anti-DNA autoantibody generation in SLE. Our data conclude that modification of mtDNA by ONOO ^– causes structural perturbations, resulting in the generation of neo-epitopes, and making it a potential immunogen in SLE. The mtDNA modified by ONOO ^– may be useful in evaluating the progression of SLE and in elucidating the mechanisms of disease pathogenesis.

Keywords

Mitochondrial DNA SLE peroxynitrite SLE IgG

Get full access to this article

View all access options for this article.

References

Gomez-Cabrera

Sanchis-Gomar

Garcia-Valles

. Mitochondria as sources and targets of damage in cellular aging. Clin Chem Lab Med 2012; 50: 1287–1295.

Kirkinezos

Moraes

. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 2001; 12: 449–457.

Giulivi

. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J 1998; 332: 673–679.

Giulivi

Poderoso

Boveris

. Production of nitric oxide by mitochondria. J Biol Chem 1998; 273: 11038–11043.

Nakamoto

Kaneko

Tahara

. Regular exercise reduces 8-oxodG in the nuclear and mitochondrial DNA and modulates the DNA repair activity in the liver of old rats. Exp Gerontol 2007; 42: 287–295.

de Souza-Pinto

Hogue

Bohr

. DNA repair and aging in mouse liver: 8-oxodG glycosylase activity increase in mitochondrial but not in nuclear extracts. Free Radic Biol Med 2001; 30: 916–923.

Hiona

Leeuwenburgh

. The role of mitochondrial DNA mutations in aging and sarcopenia: Implications for the mitochondrial vicious cycle theory of aging. Exp Gerontology 2008; 43: 24–33.

Kim

Sikder

Singh

. A colony color method identifies the vulnerability of mitochondria to oxidative damage. Mutagenesis 2002; 17: 375–381.

Reimer

Rubin

Kotzin

Tan

. Anti-native DNA antibodies from autoimmune sera also bind to DNA in mitochondria. J Immunol 1984; 133: 2532–2536.

10.

Gurevitz

Snyder

Wessel

Frey

Williamson

. Systemic lupus erythematosus: A review of the disease and treatment options. Consult Pharm 2013; 28: 110–121.

11.

Choi

Kim

Craft

. The pathogenesis of systemic lupus erythematosus—an update. Curr Opin Immunol 2012; 24: 651–657.

12.

Radic

Herrmann

van der Vlag

Rekvig

. Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity 2011; 44: 349–356.

13.

Gergely

Jr Grossman

Niland

. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46: 175–190.

14.

Askanase

Shum

Mitnick

. Systemic lupus erythematosus: An overview. Soc Work Health Care 2012; 51: 576–586.

15.

Kurien

Scofield

. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008; 7: 567–573.

16.

Ahmad R, Ahsan H. Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus. Clin Exp Med. Epub ahead of print 23 November 2012.

17.

Cai

König

Khan

Qiu

Kaphalia

Ansari

. Autoimmune response in MRL^+/⁺ mice following treatment with dichloroacetylchloride or dichloroacetic anhydride. Toxicol Appl Pharmacol 2006; 216: 248–255.

18.

Pisetsky

Grudier

Gilkeson

. A role for the immunogenic DNA in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1990; 33: 159–164.

19.

Munns

Liszewski

Hahn

. Antibody-nucleic acid complexes. Conformational and base specificities associated with spontaneously occurring poly- and monoclonal anti-DNA antibodies from autoimmune mice. Biochemistry 1984; 23: 2964–2970.

20.

Al-Shobaili

Al Robaee

Alzolibani

Rasheed

. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: Role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis Markers 2012; 33: 19–34.

21.

Calcerrada

Peluffo

Radi

. Nitric oxide-derived oxidants with a focus on peroxynitrite: Molecular targets, cellular responses and therapeutic implications. Curr Pharm Des 2011; 17: 3905–3932.

22.

Ahmad

Rasheed

Ahsan

. Biochemical and cellular toxicology of peroxynitrite: Implications in cell death and autoimmune phenomenon. Immunopharmacol Immunotoxicol 2009; 31: 388–396.

23.

Chen

Han

. Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation. Food Chem Toxicol 2011; 49: 2439–2444.

24.

Cantoni

Guidarelli

. Indirect mechanisms of DNA strand scission by peroxynitrite. Methods Enzymol 2008; 440: 111–120.

25.

Mazzon

De Sarro

Caputi

Cuzzocrea

. Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase. Shock 2002; 18: 434–439.

26.

Witt

Ahr

Brendler-Schwaab

Enzmann

Steinke

. Carcinogen-induced mitochondrial DNA damage in the ovo model. Toxicol In Vitro 1998; 12: 329–333.

27.

Alam

Moinuddin, Jabeen

. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell Immunol 2007; 247: 12–17.

28.

Rasheed

Al-Shobaili

Al Robaee

. Preferential recognition of peroxynitrite damaged thymidine-monophosphate by anti-DNA autoantibodies in systemic lupus erythematosus. Nucleosides Nucleotides Nucleic Acids 2012; 31: 736–751.

29.

Ashraf

Arif

Dixit

Moinuddin, Alam

. Physicochemical analysis of structural changes in DNA modified with glucose. Int J Biol Macromol 2012; 51: 604–611.

30.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

31.

American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity. Arthritis Rheum 2004; 50: 3418–3426.

32.

Rasheed

Al-Shobaili

Alzolibani

. Immunological functions of oxidized human immunoglobulin G in type 1 diabetes mellitus: Its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis Markers 2011; 31: 47–54.

33.

Al-Shobaili

Al Robaee

Alzolibani

Khan

Rasheed

. Hydroxyl radical modification of immunoglobulin g generated cross-reactive antibodies: Its potential role in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 2011; 23: 11–19.

34.

Goding

. Use of staphylococcal protein-A as an immunological reagent. Immuol Methods 1976; 20: 241–253.

35.

Rasheed

. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: Biochemical and immunological studies. Clin Biochem 2008; 41: 663–669.

36.

Rasheed

Ali

. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: Biochemical and immunological studies. Life Sci 2006; 79: 2320–2328.

37.

Hokland

Heron

. Analysis of the lymphocyte distribution during Isopaque-Ficoll isolation of mononuclear cells from human peripheral blood. J Immunol Methods 1980; 32: 31–39.

38.

Wang

Cai

Ansari

Khan

. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 2007; 229: 186–193.

39.

Kang

Hamasaki

. Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med 2003; 41: 1281–1288.

40.

Wardell

Ferguson

Chinnery

. Changes in the human mitochondrial genome after treatment of malignant disease. Mutat Res 2003; 525: 19–27.

41.

Takai

Park

Takada

Ichinose

Kitagawa

Akashi

. UV-irradiation induces oxidative damage to mitochondrial DNA primarily through hydrogen peroxide: Analysis of 8-oxodGuo by HPLC. Free Radic Res 2006; 40: 1138–1148.

42.

Richter

. Reactive oxygen and DNA damage in mitochondria. Mutat Res 1992; 275: 249–255.

43.

Vallance

Moncada

. Nitric oxide—from mediator to medicines. J R Coll Physicians Lond 1994; 28: 209–219.

44.

MacMicking

Xie

Nathan

. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323–350.

45.

Brown

. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999; 1411: 351–369.

46.

Nisoli

Clementi

Paolucci

. Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science 2003; 299: 896–899.

47.

Brown

Foxwell

Moncada

. Transcellular regulation of cell respiration by nitric oxide generated by activated macrophages. FEBS Lett 1998; 439: 321–324.

48.

Pryor

Squadrito

. Chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Phys 1995; 268(5 Pt 1): L699–L722.

49.

Beckman

Chen

Marshall

Frecman

. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620–1624.

50.

Murphy

. Nitric oxide and cell death. Biochim Biophys Acta 1999; 1411: 401–414.

51.

Szabo

Ohshima

. DNA damage induced by peroxynitrite: Subsequent biological effects. Nitric Oxide 1997; 1: 373–385.

52.

Sherer

Gorstein

Fritzler

Shoenfeld

. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34: 501–537.

53.

Ahsan

Ali

. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 2003; 131: 398–404.

54.

Perl

Hanczko

Doherty

. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Biol 2012; 900: 61–89.

55.

Nagy

Barcza

Gonchoroff

Phillips

Perl

. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol 2004; 173: 3676–3683.

56.

Nemirovskiy

Radabaugh

Aggarwal

. Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: Pharmacological dissection of iNOS’ role in disease. Nitric Oxide 2009; 20: 150–156.

57.

Khan

Ali

. Antibodies against nitric oxide damaged poly L-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus. J Biochem Mol Biol 2006; 39: 189–196.